National Medical Care Co. (Care), which operates hospitals and medical centers, reported a net profit of SAR 95.5 million for the first nine months of 2015, marking a 12 percent increase compared to the same period last year on higher operating and other revenues.
Item | 9m 2014 | 9m 2015 | Change |
---|---|---|---|
Revenues | 539.01 | 658.07 | 22.1 % |
Gross Income | 139.42 | 169.87 | 21.8 % |
Operating Income | 80.44 | 94.99 | 18.1 % |
Net Income | 85.18 | 95.48 | 12.1 % |
Average Shares | 44.85 | 44.85 | - |
EPS (Riyals) | 1.90 | 2.13 | 12.1 % |
The company reported a net profit of SAR 25.5 million in Q3-2015, a year-on-year growth of 23 percent.
Item | Q3 2014 | Q3 2015 | Change |
---|---|---|---|
Revenues | 177.44 | 210.78 | 18.8 % |
Gross Income | 40.16 | 50.78 | 26.5 % |
Operating Income | 18.41 | 27.13 | 47.3 % |
Net Income | 20.76 | 25.47 | 22.7 % |
Average Shares | 44.85 | 44.85 | - |
EPS (Riyals) | 0.46 | 0.57 | 22.7 % |
Item | Q2 2015 | Q3 2015 | Change |
---|---|---|---|
Revenues | 227.86 | 210.78 | (7.5 %) |
Gross Income | 64.96 | 50.78 | (21.8 %) |
Operating Income | 38.75 | 27.13 | (30.0 %) |
Net Income | 42.29 | 25.47 | (39.8 %) |
Average Shares | 44.85 | 44.85 | - |
EPS (Riyals) | 0.94 | 0.57 | (39.8 %) |
Period | Revenues | Change | Gross Income | Change | Operating Income | Change |
---|---|---|---|---|---|---|
Q1 2006 | - | - | - | - | - | - |
Q2 2006 | - | - | - | - | - | - |
Q3 2006 | - | - | - | - | - | - |
Q4 2006 | - | - | - | - | - | - |
2006 | - | - | - | - | - | - |
Q1 2007 | - | - | - | - | - | - |
Q2 2007 | - | - | - | - | - | - |
Q3 2007 | - | - | - | - | - | - |
Q4 2007 | - | - | - | - | - | - |
2007 | - | - | - | - | - | - |
Q1 2008 | - | - | - | - | - | - |
Q2 2008 | - | - | - | - | - | - |
Q3 2008 | - | - | - | - | - | - |
Q4 2008 | - | - | - | - | - | - |
2008 | - | - | - | - | - | - |
Q1 2009 | 91.40 | - | 20.01 | - | 18.41 | - |
Q2 2009 | 95.71 | - | 19.86 | - | 18.66 | - |
Q3 2009 | 91.41 | - | 13.72 | - | 12.85 | - |
Q4 2009 | 95.93 | - | 22.60 | - | 5.26 | - |
2009 | 374.46 | - | 76.19 | - | 55.19 | - |
Q1 2010 | 110.53 | 20.9 % | 29.63 | 48.1 % | 25.92 | 40.8 % |
Q2 2010 | 110.45 | 15.4 % | 26.13 | 31.6 % | 20.87 | 11.8 % |
Q3 2010 | 95.98 | 5.0 % | 23.35 | 70.2 % | 18.86 | 46.8 % |
Q4 2010 | 109.27 | 13.9 % | 24.73 | 9.4 % | 16.44 | 212.5 % |
2010 | 426.22 | 13.8 % | 103.83 | 36.3 % | 82.09 | 48.7 % |
Q1 2011 | 114.09 | 3.2 % | 34.44 | 16.2 % | 28.80 | 11.1 % |
Q2 2011 | 119.28 | 8.0 % | 34.44 | 31.8 % | 27.76 | 33.0 % |
Q3 2011 | 106.50 | 11.0 % | 24.26 | 3.9 % | 18.42 | (2.3 %) |
Q4 2011 | 118.41 | 8.4 % | 28.19 | 14.0 % | 20.19 | 22.8 % |
2011 | 458.28 | 7.5 % | 121.33 | 16.9 % | 95.18 | 15.9 % |
Q1 2012 | 128.87 | 13.0 % | 35.53 | 3.2 % | 28.74 | (0.2 %) |
Q2 2012 | 137.27 | 15.1 % | 37.60 | 9.2 % | 30.40 | 9.5 % |
Q3 2012 | 121.00 | 13.6 % | 30.07 | 23.9 % | 21.63 | 17.4 % |
Q4 2012 | 137.61 | 16.2 % | 31.93 | 13.3 % | 23.24 | 15.1 % |
2012 | 524.75 | 14.5 % | 135.13 | 11.4 % | 104.01 | 9.3 % |
Q1 2013 | 145.36 | 12.8 % | 38.75 | 9.0 % | 31.05 | 8.0 % |
Q2 2013 | 142.20 | 3.6 % | 31.78 | (15.5 %) | 21.64 | (28.8 %) |
Q3 2013 | 134.56 | 11.2 % | 24.08 | (19.9 %) | 17.45 | (19.3 %) |
Q4 2013 | 164.16 | 19.3 % | 33.54 | 5.0 % | 21.42 | (7.8 %) |
2013 | 586.28 | 11.7 % | 130.06 | (3.8 %) | 91.55 | (12.0 %) |
Q1 2014 | 181.82 | 25.1 % | 42.99 | 10.9 % | 31.12 | 0.2 % |
Q2 2014 | 179.74 | 26.4 % | 56.27 | 77.0 % | 29.95 | 38.4 % |
Q3 2014 | 177.44 | 31.9 % | 40.16 | 66.8 % | 18.41 | 5.5 % |
Q4 2014 | 194.99 | 18.8 % | 37.85 | 12.9 % | 12.23 | (42.9 %) |
2014 | 733.99 | 25.2 % | 177.27 | 36.3 % | 92.67 | 1.2 % |
Q1 2015 | 219.43 | 20.7 % | 54.12 | 25.9 % | 29.12 | (6.4 %) |
Q2 2015 | 227.86 | 26.8 % | 64.96 | 15.4 % | 38.75 | 29.4 % |
Q3 2015 | 210.78 | 18.8 % | 50.78 | 26.5 % | 27.13 | 47.3 % |
Period | Revenues | Change | Gross Income | Change | Operating Income | Change |
---|---|---|---|---|---|---|
2005 | - | - | - | - | - | - |
2006 | - | - | - | - | - | - |
2007 | - | - | - | - | - | - |
2008 | - | - | - | - | - | - |
2009 | 374.46 | - | 76.19 | - | 55.19 | - |
2010 | 426.22 | 13.8 % | 103.83 | 36.3 % | 82.09 | 48.7 % |
2011 | 458.28 | 7.5 % | 121.33 | 16.9 % | 95.18 | 15.9 % |
2012 | 524.75 | 14.5 % | 135.13 | 11.4 % | 104.01 | 9.3 % |
2013 | 586.28 | 11.7 % | 130.06 | (3.8 %) | 91.55 | (12.0 %) |
2014 | 733.99 | 25.2 % | 177.27 | 36.3 % | 92.67 | 1.2 % |
Period | Net Income | Change | EPS(Riyal) | Extraordinary Income/Expense | Net Profit Before Unusual Items | EPS Before XO Items |
---|---|---|---|---|---|---|
Q1 2006 | - | - | - | - | - | - |
Q2 2006 | - | - | - | - | - | - |
Q3 2006 | - | - | - | - | - | - |
Q4 2006 | - | - | - | - | - | - |
2006 | - | - | - | - | - | - |
Q1 2007 | - | - | - | - | - | - |
Q2 2007 | - | - | - | - | - | - |
Q3 2007 | - | - | - | - | - | - |
Q4 2007 | - | - | - | - | - | - |
2007 | - | - | - | - | - | - |
Q1 2008 | - | - | - | - | - | - |
Q2 2008 | - | - | - | - | - | - |
Q3 2008 | - | - | - | - | - | - |
Q4 2008 | - | - | - | - | - | - |
2008 | - | - | - | - | - | - |
Q1 2009 | 18.07 | - | 0.40 | - | 18.07 | 0.40 |
Q2 2009 | 17.04 | - | 0.38 | - | 17.04 | 0.38 |
Q3 2009 | 15.88 | - | 0.35 | - | 15.88 | 0.35 |
Q4 2009 | 5.72 | - | 0.13 | - | 5.72 | 0.13 |
2009 | 56.71 | - | 1.26 | - | 56.71 | 1.26 |
Q1 2010 | 25.67 | 42.1 % | 0.57 | - | 25.67 | 0.57 |
Q2 2010 | 20.70 | 21.5 % | 0.46 | - | 20.70 | 0.46 |
Q3 2010 | 20.51 | 29.2 % | 0.46 | - | 20.51 | 0.46 |
Q4 2010 | 17.87 | 212.4 % | 0.40 | - | 17.87 | 0.40 |
2010 | 84.75 | 49.4 % | 1.89 | - | 84.75 | 1.89 |
Q1 2011 | 28.58 | 11.3 % | 0.64 | - | 28.58 | 0.64 |
Q2 2011 | 28.64 | 38.4 % | 0.64 | - | 28.64 | 0.64 |
Q3 2011 | 18.54 | (9.6 %) | 0.41 | - | 18.54 | 0.41 |
Q4 2011 | 18.96 | 6.1 % | 0.42 | - | 18.96 | 0.42 |
2011 | 94.72 | 11.8 % | 2.11 | - | 94.72 | 2.11 |
Q1 2012 | 28.88 | 1.0 % | 0.64 | - | 28.88 | 0.64 |
Q2 2012 | 29.59 | 3.3 % | 0.66 | - | 29.59 | 0.66 |
Q3 2012 | 21.46 | 15.7 % | 0.48 | - | 21.46 | 0.48 |
Q4 2012 | 25.03 | 32.0 % | 0.56 | - | 25.03 | 0.56 |
2012 | 104.96 | 10.8 % | 2.34 | - | 104.96 | 2.34 |
Q1 2013 | 31.12 | 7.8 % | 0.69 | - | 31.12 | 0.69 |
Q2 2013 | 22.19 | (25.0 %) | 0.49 | - | 22.19 | 0.49 |
Q3 2013 | 18.80 | (12.4 %) | 0.42 | - | 18.80 | 0.42 |
Q4 2013 | 20.39 | (18.6 %) | 0.45 | - | 20.39 | 0.45 |
2013 | 92.50 | (11.9 %) | 2.06 | - | 92.50 | 2.06 |
Q1 2014 | 32.40 | 4.1 % | 0.72 | - | 32.40 | 0.72 |
Q2 2014 | 31.06 | 40.0 % | 0.69 | - | 31.06 | 0.69 |
Q3 2014 | 20.76 | 10.4 % | 0.46 | - | 20.76 | 0.46 |
Q4 2014 | 10.28 | (49.6 %) | 0.23 | - | 10.28 | 0.23 |
2014 | 95.46 | 3.2 % | 2.13 | - | 95.46 | 2.13 |
Q1 2015 | 27.72 | (14.4 %) | 0.62 | - | 27.72 | 0.62 |
Q2 2015 | 42.29 | 36.1 % | 0.94 | - | 42.29 | 0.94 |
Q3 2015 | 25.47 | 22.7 % | 0.57 | - | 25.47 | 0.57 |
Period | Net Income | Change | EPS(Riyal) | Extraordinary Income/Expense | Net Profit Before Unusual Items | EPS Before XO Items |
---|---|---|---|---|---|---|
2005 | - | - | - | - | - | - |
2006 | - | - | - | - | - | - |
2007 | - | - | - | - | - | - |
2008 | - | - | - | - | - | - |
2009 | 56.71 | - | 1.26 | - | 56.71 | 1.26 |
2010 | 84.75 | 49.4 % | 1.89 | - | 84.75 | 1.89 |
2011 | 94.72 | 11.8 % | 2.11 | - | 94.72 | 2.11 |
2012 | 104.96 | 10.8 % | 2.34 | - | 104.96 | 2.34 |
2013 | 92.50 | (11.9 %) | 2.06 | - | 92.50 | 2.06 |
2014 | 95.46 | 3.2 % | 2.13 | - | 95.46 | 2.13 |
Period | Gross Margin | OIBDA Margin | Net Margin Before Unusual Items |
---|---|---|---|
Q1 2006 | - | - | - |
Q2 2006 | - | - | - |
Q3 2006 | - | - | - |
Q4 2006 | - | - | - |
2006 | - | - | - |
Q1 2007 | - | - | - |
Q2 2007 | - | - | - |
Q3 2007 | - | - | - |
Q4 2007 | - | - | - |
2007 | - | - | - |
Q1 2008 | - | - | - |
Q2 2008 | - | - | - |
Q3 2008 | - | - | - |
Q4 2008 | - | - | - |
2008 | - | - | - |
Q1 2009 | - | - | - |
Q2 2009 | - | - | - |
Q3 2009 | - | - | - |
Q4 2009 | 20.35 % | 20.91 % | 15.14 % |
2009 | 20.35 % | 20.91 % | 15.14 % |
Q1 2010 | 21.80 % | 22.04 % | 16.34 % |
Q2 2010 | 22.55 % | 22.04 % | 16.65 % |
Q3 2010 | 24.63 % | 23.32 % | 17.58 % |
Q4 2010 | 24.36 % | 25.12 % | 19.88 % |
2010 | 24.36 % | 25.12 % | 19.88 % |
Q1 2011 | 25.28 % | 25.61 % | 20.40 % |
Q2 2011 | 26.67 % | 26.85 % | 21.80 % |
Q3 2011 | 26.24 % | 26.11 % | 20.85 % |
Q4 2011 | 26.48 % | 26.55 % | 20.67 % |
2011 | 26.48 % | 26.56 % | 20.67 % |
Q1 2012 | 25.88 % | 25.84 % | 20.09 % |
Q2 2012 | 25.57 % | 25.38 % | 19.54 % |
Q3 2012 | 25.99 % | 25.46 % | 19.56 % |
Q4 2012 | 25.75 % | 25.14 % | 20.00 % |
2012 | 25.75 % | 25.14 % | 20.00 % |
Q1 2013 | 25.56 % | 24.89 % | 19.81 % |
Q2 2013 | 24.27 % | 23.17 % | 18.27 % |
Q3 2013 | 22.61 % | 21.99 % | 17.36 % |
Q4 2013 | 21.86 % | 20.98 % | 15.78 % |
2013 | 22.18 % | 20.98 % | 15.78 % |
Q1 2014 | 21.26 % | 20.31 % | 15.06 % |
Q2 2014 | 23.76 % | 21.17 % | 15.55 % |
Q3 2014 | 24.60 % | 20.97 % | 14.88 % |
Q4 2014 | 24.15 % | 19.46 % | 12.88 % |
2014 | 24.15 % | 19.59 % | 13.01 % |
Q1 2015 | 24.42 % | 18.66 % | 11.64 % |
Q2 2015 | 24.04 % | 18.90 % | 12.33 % |
Q3 2015 | 24.35 % | 19.23 % | 12.40 % |
Period | Gross Margin | OIBDA Margin | Net Margin Before Unusual Items |
---|---|---|---|
2005 | - | - | - |
2006 | - | - | - |
2007 | - | - | - |
2008 | - | - | - |
2009 | 20.35 % | 20.91 % | 15.14 % |
2010 | 24.36 % | 25.12 % | 19.88 % |
2011 | 26.48 % | 26.56 % | 20.67 % |
2012 | 25.75 % | 25.14 % | 20.00 % |
2013 | 22.18 % | 20.98 % | 15.78 % |
2014 | 24.15 % | 19.59 % | 13.01 % |
Period | Gross Margin | OIBDA Margin | Net Margin Before Unusual Items |
---|---|---|---|
Q1 2006 | - | - | - |
Q2 2006 | - | - | - |
Q3 2006 | - | - | - |
Q4 2006 | - | - | - |
Q1 2007 | - | - | - |
Q2 2007 | - | - | - |
Q3 2007 | - | - | - |
Q4 2007 | - | - | - |
Q1 2008 | - | - | - |
Q2 2008 | - | - | - |
Q3 2008 | - | - | - |
Q4 2008 | - | - | - |
Q1 2009 | 21.89 % | 25.72 % | 19.77 % |
Q2 2009 | 20.75 % | 24.92 % | 17.80 % |
Q3 2009 | 15.01 % | 20.39 % | 17.37 % |
Q4 2009 | 23.56 % | 12.80 % | 5.96 % |
Q1 2010 | 26.81 % | 28.92 % | 23.22 % |
Q2 2010 | 23.66 % | 24.55 % | 18.74 % |
Q3 2010 | 24.33 % | 25.97 % | 21.37 % |
Q4 2010 | 22.63 % | 21.09 % | 16.35 % |
Q1 2011 | 30.19 % | 30.66 % | 25.05 % |
Q2 2011 | 28.87 % | 29.19 % | 24.01 % |
Q3 2011 | 22.78 % | 22.91 % | 17.41 % |
Q4 2011 | 23.81 % | 23.21 % | 16.01 % |
Q1 2012 | 27.57 % | 27.57 % | 22.41 % |
Q2 2012 | 27.39 % | 27.12 % | 21.56 % |
Q3 2012 | 24.85 % | 23.55 % | 17.74 % |
Q4 2012 | 23.20 % | 22.29 % | 18.19 % |
Q1 2013 | 26.65 % | 26.37 % | 21.41 % |
Q2 2013 | 22.35 % | 20.42 % | 15.60 % |
Q3 2013 | 17.89 % | 18.61 % | 13.97 % |
Q4 2013 | 20.43 % | 18.63 % | 12.42 % |
Q1 2014 | 23.64 % | 22.99 % | 17.82 % |
Q2 2014 | 31.31 % | 23.55 % | 17.28 % |
Q3 2014 | 22.63 % | 18.45 % | 11.70 % |
Q4 2014 | 19.41 % | 13.33 % | 5.27 % |
Q1 2015 | 24.67 % | 19.55 % | 12.63 % |
Q2 2015 | 28.51 % | 23.38 % | 18.56 % |
Q3 2015 | 24.09 % | 19.85 % | 12.09 % |
Period | Shares Outstanding (M) | EPS (Riyal) | Adjusted EPS (Riyal) | Book Value (BV) |
---|---|---|---|---|
Q1 2006 | - | - | - | - |
Q2 2006 | - | - | - | - |
Q3 2006 | - | - | - | - |
Q4 2006 | - | - | - | - |
Q1 2007 | - | - | - | - |
Q2 2007 | - | - | - | - |
Q3 2007 | - | - | - | - |
Q4 2007 | - | - | - | - |
Q1 2008 | - | - | - | - |
Q2 2008 | - | - | - | - |
Q3 2008 | - | - | - | - |
Q4 2008 | - | - | - | - |
Q1 2009 | 44.85 | - | - | 8.46 |
Q2 2009 | 44.85 | - | - | 8.84 |
Q3 2009 | 44.85 | - | - | 9.19 |
Q4 2009 | 44.85 | 1.26 | 1.26 | 9.29 |
Q1 2010 | 44.85 | 1.43 | 1.43 | 9.87 |
Q2 2010 | 44.85 | 1.52 | 1.52 | 9.99 |
Q3 2010 | 44.85 | 1.62 | 1.62 | 10.45 |
Q4 2010 | 44.85 | 1.89 | 1.89 | 10.85 |
Q1 2011 | 44.85 | 1.95 | 1.95 | 10.85 |
Q2 2011 | 44.85 | 2.13 | 2.13 | 11.49 |
Q3 2011 | 44.85 | 2.09 | 2.09 | 11.90 |
Q4 2011 | 44.85 | 2.11 | 2.11 | 12.32 |
Q1 2012 | 44.85 | 2.12 | 2.12 | 12.97 |
Q2 2012 | 44.85 | 2.14 | 2.14 | 12.57 |
Q3 2012 | 44.85 | 2.20 | 2.20 | 13.04 |
Q4 2012 | 44.85 | 2.34 | 2.34 | 13.60 |
Q1 2013 | 44.85 | 2.39 | 2.39 | 18.19 |
Q2 2013 | 44.85 | 2.23 | 2.23 | 17.24 |
Q3 2013 | 44.85 | 2.17 | 2.17 | 17.65 |
Q4 2013 | 44.85 | 2.06 | 2.06 | 18.11 |
Q1 2014 | 44.85 | 2.09 | 2.09 | 17.28 |
Q2 2014 | 44.85 | 2.29 | 2.29 | 17.97 |
Q3 2014 | 44.85 | 2.33 | 2.33 | 18.46 |
Q4 2014 | 44.85 | 2.11 | 2.11 | 18.69 |
Q1 2015 | 44.85 | 2.00 | 2.00 | 19.26 |
Q2 2015 | 44.85 | 2.25 | 2.25 | 18.66 |
Q3 2015 | 44.85 | 2.36 | 2.36 | 19.22 |
Period | Shares Outstanding (M) | EPS (Riyal) | Adjusted EPS (Riyal) | Book Value (BV) |
---|---|---|---|---|
2005 | - | - | - | - |
2006 | - | - | - | - |
2007 | - | - | - | - |
2008 | - | - | - | - |
2009 | 44.85 | 1.26 | 1.26 | 9.29 |
2010 | 44.85 | 1.89 | 1.89 | 10.85 |
2011 | 44.85 | 2.11 | 2.11 | 12.32 |
2012 | 44.85 | 2.34 | 2.34 | 13.60 |
2013 | 44.85 | 2.06 | 2.06 | 18.11 |
2014 | 44.85 | 2.13 | 2.13 | 18.69 |
Period | P/E | Adjusted P/E | Price/book |
---|---|---|---|
Q1 2006 | - | - | - |
Q2 2006 | - | - | - |
Q3 2006 | - | - | - |
Q4 2006 | - | - | - |
Q1 2007 | - | - | - |
Q2 2007 | - | - | - |
Q3 2007 | - | - | - |
Q4 2007 | - | - | - |
Q1 2008 | - | - | - |
Q2 2008 | - | - | - |
Q3 2008 | - | - | - |
Q4 2008 | - | - | - |
Q1 2009 | - | - | - |
Q2 2009 | - | - | - |
Q3 2009 | - | - | - |
Q4 2009 | - | - | - |
Q1 2010 | - | - | - |
Q2 2010 | - | - | - |
Q3 2010 | - | - | - |
Q4 2010 | - | - | - |
Q1 2011 | - | - | - |
Q2 2011 | - | - | - |
Q3 2011 | - | - | - |
Q4 2011 | - | - | - |
Q1 2012 | - | - | - |
Q2 2012 | - | - | - |
Q3 2012 | - | - | - |
Q4 2012 | - | - | - |
Q1 2013 | 30.02 | 30.02 | 3.94 |
Q2 2013 | 26.07 | 26.07 | 3.37 |
Q3 2013 | 25.16 | 25.16 | 3.09 |
Q4 2013 | 26.43 | 26.43 | 3.01 |
Q1 2014 | 29.41 | 29.41 | 3.56 |
Q2 2014 | 32.48 | 32.48 | 4.14 |
Q3 2014 | 32.55 | 32.55 | 4.11 |
Q4 2014 | 26.03 | 26.03 | 2.94 |
Q1 2015 | 30.88 | 30.88 | 3.21 |
Q2 2015 | 28.44 | 28.44 | 3.44 |
Q3 2015 | 22.37 | 22.37 | 2.74 |
Period | P/E | Adjusted P/E | Price/book |
---|---|---|---|
2005 | - | - | - |
2006 | - | - | - |
2007 | - | - | - |
2008 | - | - | - |
2009 | - | - | - |
2010 | - | - | - |
2011 | - | - | - |
2012 | - | - | - |
2013 | 26.43 | 26.43 | 3.01 |
2014 | 25.77 | 25.77 | 2.94 |
Q3 2015
2015
Period | Medical Services | Pharmacies |
---|---|---|
Q1 2010 | 85.68 | 24.84 |
Q2 2010 | 84.16 | 26.29 |
Q3 2010 | 74.56 | 21.42 |
Q4 2010 | 84.07 | 25.20 |
Q1 2011 | 89.20 | 24.89 |
Q2 2011 | 94.51 | 24.77 |
Q3 2011 | 84.02 | 22.49 |
Q4 2011 | 93.61 | 24.79 |
Q1 2012 | 102.83 | 26.04 |
Q2 2012 | 109.44 | 27.83 |
Q3 2012 | 96.87 | 24.14 |
Q4 2012 | 109.84 | 27.76 |
Q1 2013 | 117.72 | 27.65 |
Q2 2013 | 115.21 | 26.98 |
Q3 2013 | 109.28 | 25.28 |
Q4 2013 | 134.04 | 30.12 |
Q1 2014 | 149.16 | 32.67 |
Q2 2014 | 149.31 | 30.43 |
Q3 2014 | 149.57 | 27.87 |
Q4 2014 | 161.93 | 33.06 |
Q1 2015 | 184.80 | 34.63 |
Q2 2015 | 196.41 | 31.45 |
Q3 2015 | 180.37 | 30.41 |
Period | Medical Services | Pharmacies |
---|---|---|
2010 | 328.47 | 97.75 |
2011 | 361.34 | 96.95 |
2012 | 418.98 | 105.76 |
2013 | 476.25 | 110.02 |
2014 | 609.97 | 124.03 |
Item | Q3 2015 (e) | Q3 2015 (a) | Change |
---|---|---|---|
Average | 27.70 | 25.47 | (8.0 %) |
Item | Q3 2015 (e) | Q3 2015 (a) | Change |
---|---|---|---|
OSOOL AND BAKHEET | 26.00 | 25.47 | (2.0) % |
SFC | 26.00 | 25.47 | (2.0) % |
99Hlala Capital | 28.00 | 25.47 | (9.0) % |
AlJazira Capital | 30.80 | 25.47 | (17.3) % |
Current | |
Market Cap (M Riyal) | 7,364.37 |
Enterprise Value (EV) (M) | 7,348.86 |
Shares Outstanding ((M)) | 44.85 |
EPS ( Riyal) (TTM) | 6.12 |
Book Value (BV) ( Riyal) | 34.35 |
Par Value ( Riyal) | 10.00 |
Adjusted P/E (Last12) | 30.00 |
P/E (TTM) | 26.83 |
Price/book | 4.78 |
Return on Average Assets (%) (TTM) | 13.3 |
Return on Average Equity (%) (TTM) | 18.7 |
Argaam Investment Company has updated the Privacy Policy of its services and digital platforms. Know more about our Privacy Policy here.
Argaam uses cookies to personalize content, to provide social media features and analyze traffic, that we might also share with third parties. You consent to our cookies if you use this website
Comments {{getCommentCount()}}
Be the first to comment
رد{{comment.DisplayName}} على {{getCommenterName(comment.ParentThreadID)}}
{{comment.DisplayName}}
{{comment.ElapsedTime}}